MétaCan
Menu
Back to cohort
Record W2885983038 · doi:10.7326/l18-0236

Risk-Targeted Lung Cancer Screening

2018· letter· en· W2885983038 on OpenAlexaffabout
Sonya Cressman, Kevin ten Haaf, Stephen Lam, Martin C. Tammemägi

Bibliographic record

VenueAnnals of Internal Medicine · 2018
Typeletter
Languageen
FieldMedicine
TopicLung Cancer Diagnosis and Treatment
Canadian institutionsBrock UniversityBC Cancer Agency
Fundersnot available
KeywordsMedicineLung cancerNational Lung Screening TrialPopulationFamily medicineColorectal cancerInternal medicineCancerOncologyGynecologyLung cancer screeningEnvironmental health

Abstract

fetched live from OpenAlex

Letters7 August 2018Risk-Targeted Lung Cancer ScreeningSonya Cressman, PhD, MBA, Kevin ten Haaf, MSc, Stephen Lam, MD, and Martin Tammemägi, DVM, MSc, PhDSonya Cressman, PhD, MBAThe British Columbia Cancer Agency, Vancouver, British Columbia, Canada (S.C., S.L.)Search for more papers by this author, Kevin ten Haaf, MScErasmus University Medical Center, Rotterdam, the Netherlands (K.T.)Search for more papers by this author, Stephen Lam, MDThe British Columbia Cancer Agency, Vancouver, British Columbia, Canada (S.C., S.L.)Search for more papers by this author, and Martin Tammemägi, DVM, MSc, PhDBrock University, St. Catharines, Ontario, Canada (M.T.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L18-0236 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Kumar and colleagues (1) conducted a cost-effectiveness analysis (CEA) comparing lung cancer screening using risk-based criteria versus criteria based on NLST (National Lung Screening Trial) enrollment. They concluded, “Our analysis suggests that the gains from such risk-based eligibility likely would be small,” implying approximate equivalence between these criteria. A critical limitation of their analysis is that their sample was limited to NLST participants and does not represent the general population of smokers. Of note, they did not evaluate smokers who met risk-based but not NLST criteria. Consider using NLST criteria and the Prostate, Lung, Colorectal, and Ovarian ...References1. Kumar V, Cohen JT, van Klaveren D, Soeteman DI, Wong JB, Neumann PJ, et al. Risk-targeted lung cancer screening: a cost-effectiveness analysis. Ann Intern Med. 2018;168:161-9. [PMID: 29297005]. doi:10.7326/M17-1401 LinkGoogle Scholar2. Tammemägi MC, Katki HA, Hocking WG, Church TR, Caporaso N, Kvale PA, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368:728-36. [PMID: 23425165] doi:10.1056/NEJMoa1211776 CrossrefMedlineGoogle Scholar3. Tammemägi MC, Church TR, Hocking WG, Silvestri GA, Kvale PA, Riley TL, et al. Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts. PLoS Med. 2014;11:e1001764. [PMID: 25460915] doi:10.1371/journal.pmed.1001764 CrossrefMedlineGoogle Scholar4. Cressman S, Peacock SJ, Tammemägi MC, Evans WK, Leighl NB, Goffin JR, et al. The cost-effectiveness of high-risk lung cancer screening and drivers of program efficiency. J Thorac Oncol. 2017;12:1210-22. [PMID: 28499861] doi:10.1016/j.jtho.2017.04.021 CrossrefMedlineGoogle Scholar5. Ten Haaf K, Tammemägi MC, Bondy SJ, van der Aalst CM, Gu S, McGregor SE, et al. Performance and cost-effectiveness of computed tomography lung cancer screening scenarios in a population-based setting: a microsimulation modeling analysis in ontario, canada. PLoS Med. 2017;14:e1002225. [PMID: 28170394] doi:10.1371/journal.pmed.1002225 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: The British Columbia Cancer Agency, Vancouver, British Columbia, Canada (S.C., S.L.)Erasmus University Medical Center, Rotterdam, the Netherlands (K.T.)Brock University, St. Catharines, Ontario, Canada (M.T.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L18-0236. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRisk-Targeted Lung Cancer Screening Vaibhav Kumar , Joshua T. Cohen , David van Klaveren , Djøra I. Soeteman , John B. Wong , Peter J. Neumann , and David M. Kent Risk-Targeted Lung Cancer Screening Vaibhav Kumar , Joshua T. Cohen , Peter J. Neumann , and David M. Kent Metrics Cited byLung Cancer Screening by Low-Dose Computed Tomography: Part 2 – Key Elements for Programmatic Implementation of Lung Cancer ScreeningRisk prediction models versus simplified selection criteria to determine eligibility for lung cancer screening: an analysis of German federal-wide survey and incidence data 7 August 2018Volume 169, Issue 3Page: 199-200KeywordsCancer screeningComputed axial tomographyCost effectiveness analysisDisclosureHealth economicsLung and intrathoracic tumorsLung cancer screeningPrevention, policy, and public healthPublic policySocioeconomic status ePublished: 7 August 2018 Issue Published: 7 August 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.031
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.049
Threshold uncertainty score0.162

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.031
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.001
Scholarly communication0.0020.001
Open science0.0010.001
Research integrity0.0030.003
Insufficient payload (model declined to judge)0.0490.011

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.046
GPT teacher head0.382
Teacher spread0.337 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueAnnals of Internal MedicineSame topicLung Cancer Diagnosis and TreatmentFrench-language works237,207